Abbott Laboratories (ABT) — Business segments and KPIs
Revenue by business segment and geography for Abbott Laboratories, with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Medical Devices | 21.39B | 48.3% |
| Diagnostic Products | 8.94B | 20.2% |
| Nutritional Products | 8.45B | 19.1% |
| Established Pharmaceutical Products | 5.54B | 12.5% |
| Revenue by region | ||
| UNITED STATES | 17.13B | 39.8% |
| Non-US | 15.98B | 37.2% |
| D [E] | 2.76B | 6.4% |
| C [N] | 1.91B | 4.4% |
| C [H] | 1.87B | 4.4% |
| I [N] | 1.87B | 4.4% |
| J [P] | 1.48B | 3.4% |